Colgate-Palmolive (NYSE:CL) Stock Holdings Decreased by Orser Capital Management LLC

Orser Capital Management LLC lessened its position in Colgate-Palmolive (NYSE:CL) by 1.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 23,279 shares of the company’s stock after selling 380 shares during the quarter. Colgate-Palmolive makes up about 1.6% of Orser Capital Management LLC’s holdings, making the stock its 20th biggest holding. Orser Capital Management LLC’s holdings in Colgate-Palmolive were worth $2,116,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $64,000. True Wealth Design LLC grew its position in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after purchasing an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC increased its stake in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after buying an additional 368 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

CL opened at $87.90 on Thursday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock’s 50 day moving average price is $92.36 and its two-hundred day moving average price is $97.92. The firm has a market capitalization of $71.82 billion, a P/E ratio of 25.19, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is 57.31%.

Analyst Ratings Changes

Several equities analysts have recently commented on CL shares. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $103.63.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.37% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.